Pregnancy is a state where high and stage-dependent plasticity of the maternal immune system is necessary in order to equilibrate between immunosuppression of harmful responses towards the fetus and ability to fight infections. TCR γδ cells have been implicated in the responses in infectious diseases, in the regulation of immune responses, and in tissue homeostasis and repair. The variety of functions makes γδ T cells a particularly interesting population during pregnancy. In this study, we investigated the proportion, phenotype and TCR γ and δ repertoires of γδ T cells at the maternal–fetal interface and in the blood of pregnant women using FACS, immunohistochemistry and spectratyping. We found an enrichment of activated and terminally differentiated pro-inflammatory γδ T-cell effectors with specific location in the human decidua during early pregnancy, while no significant changes in their counterparts in the blood of pregnant women were observed. Our spectratyping data revealed polyclonal CDR3 repertoires of the δ1, δ2 and δ3 chains and γ2, γ3, γ4 and γ5 chains and oligoclonal and highly restricted CDR3γ9 repertoire of γδ T cells in the decidua and blood of pregnant women. Early pregnancy induces recruitment of differentiated pro-inflammatory γδ T-cell effectors with diverse TCR repertoires at the maternal–fetal interface.
A small for gestational age (SGA) newborn is a clinical finding during pregnancy resulting from various underlying conditions, such as placental pathology, preeclampsia, gestational diabetes, and maternal obesity. SGA is usually suspected when the fetal weight falls below the 10th centile for gestational age and must be distinguished from fetal growth restriction. Aims: To evaluate the influence of prepregnancy BMI on the prevalence of SGA and fetal macrosomia at term in singleton pregnancies within a non-selected population of Bulgarian women. Materials and Methods: A total of 199 overweight (BMI 25-29.9 kg/m²) and 198 obese (BMI ≥ 30 kg/m²) women were compared with a control group of 459 women with normal prepregnancy BMI (18.5-24.9 kg/m²). Birthweight categories included: normal for gestational age (10th-90th percentile), low for gestational age (below 10th per-centile), and large for gestational age (above 90th percentile). SGA was further classified into moderate (3rd-10th percentile) and severe (below 3rd percentile). Results: Results indicated a statistically significant lower percentage of normal birth weight in the overweight group (76.88%) compared to the control group (82.57%, p = 0.044). Overweight women had a higher incidence of large for gestational age newborns (17.59%) compared to the control group (10%, p = 0.03). No significant differences were found in low birthweight or moderate SGA between groups. However, severe SGA was significantly less common in the overweight group (1%) compared to the obese group (3.54%, p = 0.0045). Macrosomia (birth weight ≥ 4000 g) was more prevalent in overweight women (10.3%) than in those with a normal BMI (5.82%, p = 0.037). Relative risk analysis showed increased risks for large for gestational age and macrosomia in overweight and obese women. Conclusions: The study emphasizes the importance of targeted interventions to control and regulate maternal weight to minimize the risk of adverse fetal and neonatal outcomes.
Uncontrolled and excessive inflammation could negatively impact embryo implantation, potentially leading to implantation failure or miscarriage. Small extracellular vesicles (sEVs) secreted by extravillous trophoblasts (EVTs) play a significant role in mediating the homeostasis at the maternal–fetal interface. In the present work we assessed the role of EVT-derived sEVs in the protection of the human blastocyst’s integrity and function in a microenvironment with excessive Th1-induced inflammation using the Sw71 blastocyst-like surrogate (Sw71 BLS) as a model of implanting a human embryo. Conditioned media from primary trophoblast-derived EVT cells were used as the source for sEVs’ isolation by precipitation. sEVs were characterized by TEM, IEM, and protein content. To simulate Th1-induced inflammation, we performed TCR stimulation and polyclonal activation of isolated T cells, which preferentially led to Th1 cytokine production. The use of the Sw71 spheroid model allowed us to monitor directly the damaging effect of high levels of Th1 cytokines on the ability of trophoblast cells to self-organize and migrate. The addition of EVT-sEVs unlocked the absolute migration capacity of the trophoblast cells in a healthy microenvironment. However, EVT-sEV treatment could not counteract the adverse effects of excessive Th1-mediated inflammation. This study provides a platform for further elucidation of the EVT-sEV dosage and potency for trophoblast functional recovery.
Maternal–fetal tolerance mechanisms are crucial during human pregnancy to prevent the immune rejection of the embryo. A well-known mechanism blocking NK-cell cytotoxicity is the interaction of their inhibitory killer-cell immunoglobulin-like receptors (iKIR) with HLA-C molecules on the target cells. In this study, we aimed to investigate the expression of iKIRs (KIR2DL1 and KIR2DL2/3) on the matched decidual and peripheral γδT cells and the localization of HLA-C ligands throughout human pregnancy. The degranulation of γδT cells of pregnant and non-pregnant women in the presence of trophoblast cells was evaluated as well. Our results showed a higher proportion of iKIR-positive γδT cells at the maternal–fetal interface early in human pregnancy compared to the paired blood of pregnant women and full-term pregnancy decidua. In accordance, HLA-C was intensively expressed by the intermediate cytotrophoblasts and decidua-invading extravillous trophoblasts (EVTs) in early but not late pregnancy. Decidual γδT cells during early pregnancy showed higher spontaneous degranulation compared to their blood pairs, but neither decidual nor peripheral γδ T cells increased their degranulation in the presence of Sw71 EVT-like cells. The latter were unable to suppress the higher cytotoxicity of γδT cells, suggesting a complex regulatory landscape beyond NK-like activity inhibition.